Tilray Brands
TLRY | NASDAQ
$2.34
-$0.09 (-3.70%)
At close: Nov 16, 2026, 4:00 PM ET
$2.35
+$0.01 (+0.36%)
After-hours:
Nov 16, 2026, 7:44 PM ET
Tilray Brands Company Profile
Company profile explainedCompany Profile
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.
Key Executives
| Name | Position |
|---|---|
| Irwin David Simon | President, Chief Executive Officer & Chairman |
| Carl A. Merton | Chief Financial Officer & Principal Accounting Officer |
| Lloyd Brathwaite | Chief Information Officer |
| Roger Savell | Chief Administrative Officer & Chief Financial Officer of International |
| Berrin Noorata | Chief Corporate Affairs Officer |
| Blair MacNeil | President of Tilray Canada |
| Denise Menikheim Faltischek | Chief Strategy Officer and Head of M&A |
| Mitchell S. Gendel | Global General Counsel & Corporate Secretary |
| Nyree Pinto | Chief Human Resources Officer |
| Prinz Pinakatt | Chief Growth Officer of Tilray Beverages |
| Rajnish Ohri | President of International |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 08, 2026 | 10-Q | Quarterly Report |
| Oct 08, 2026 | 8-K | Current Report |
| Sep 28, 2026 | ARS | Filing |
| Sep 28, 2026 | DEFA14A | Filing |
| Sep 28, 2026 | DEF 14A | Filing |
| Sep 18, 2026 | PRE 14A | Filing |
| Sep 14, 2026 | 8-K | Current Report |
| Aug 27, 2026 | 4 | Filing |
| Aug 27, 2026 | 4 | Filing |
| Aug 27, 2026 | 4 | Filing |
Tilray Brands
| Country | Canada |
| IPO Date | Jul 19, 2018 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,595 |
| CEO | Irwin David Simon |
Contact Details
265 Talbot Street West Leamington,
ON N8H 5L4 Canada
Stock Details
| Ticker Symbol | TLRY |
| Exchange | NASDAQ |
| Fiscal Year | June - May |
| Reporting Currency | USD |
| CIK Code | 0001731348 |
| CUSIP Number | 88688T209 |
| ISIN Number | US88688T2096 |
| SIC Code | 2833 |
Add to Watchlist
Select watchlists to add or remove TLRY